A sample semaglutide taper from a therapeutic dose might look like this
Less commonly recognized but still valid qualifying conditions include prediabetes (elevated fasting glucose or A1C between 5.7-6.4%), polycystic ovary syndrome, non-alcoholic fatty liver disease, osteoarthritis of weight-bearing joints, and chronic kidney disease
A well-formulated daily multivitamin can help cover those gaps and create a stronger nutritional foundation
Scientific References FDA approves tesamorelin for HIV-related lipodystrophy
The upsurge of very-low-density lipoprotein particles seems to be the core atherogenic dyslipidemia in T2DM, which is partially secondary to insulin resistance [26]
While not yet as widely available as existing therapies such as Wegovy, Ozempic, or Zepbound, its early results have positioned it as a potential next-generation obesity treatment